Cargando…
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells
We have assessed the impact of α-synuclein overexpression on the differentiation potential and phenotypic signatures of two neural-committed induced pluripotent stem cell lines derived from a Parkinson's disease patient with a triplication of the human SNCA genomic locus. In parallel, comparati...
Autores principales: | Oliveira, L M A, Falomir-Lockhart, L J, Botelho, M G, Lin, K-H, Wales, P, Koch, J C, Gerhardt, E, Taschenberger, H, Outeiro, T F, Lingor, P, Schüle, B, Arndt-Jovin, D J, Jovin, T M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670926/ https://www.ncbi.nlm.nih.gov/pubmed/26610207 http://dx.doi.org/10.1038/cddis.2015.318 |
Ejemplares similares
-
Higher Vulnerability and Stress Sensitivity of Neuronal Precursor Cells Carrying an Alpha-Synuclein Gene Triplication
por: Flierl, Adrian, et al.
Publicado: (2014) -
SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress
por: Byers, Blake, et al.
Publicado: (2011) -
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
por: Wurster, Isabel, et al.
Publicado: (2022) -
Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson’s disease
por: Zafar, Faria, et al.
Publicado: (2018) -
Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
por: Fukusumi, Hayato, et al.
Publicado: (2021)